Aaron Schuchart
Chief Business Officer, Aeglea BioTherapeutics.
Companies
- LUMOS PHARMA, INC.Chief Business Officer May 28, 2021 to Dec 13, 20241
- Aeglea BioTherapeuticsChief Business Officer Jun 14, 2017 to Mar 1, 20192
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- LUMOS PHARMA, INC.0 shares3Dec 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 12, 2024Returned to company 8,179 shares of LUMOS PHARMA, INC.3
- Apr 1, 2024Granted 1,000 shares at $2.84 of LUMOS PHARMA, INC.4
- Feb 1, 2024Shares withheld for tax 202 shares at $3.01 of LUMOS PHARMA, INC.5
- Feb 1, 2023Shares withheld for tax 104 shares at $3.52 of LUMOS PHARMA, INC.6
- Feb 1, 2023Granted 1,000 shares at $3.52 of LUMOS PHARMA, INC.6
- Feb 1, 2022Shares withheld for tax 52 shares at $10.02 of LUMOS PHARMA, INC.7
- Feb 1, 2022Granted 1,000 shares at $10.02 of LUMOS PHARMA, INC.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Apr 3, 2024
- 5SEC EDGARForm 4 filed Feb 5, 2024
- 6SEC EDGARForm 4 filed Feb 3, 2023
- 7SEC EDGARForm 4 filed Feb 3, 2022